PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy.\', \'Dermatology Section, Department of Medicine, University of Perugia, Perugia, Italy.\', \'Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.\', \'Department of Health Sciences Vincenzo Tiberio, University of Molise, Campobasso, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/dth.13502
?:hasPublicationType
?:journal
  • Dermatologic therapy
is ?:pmid of
?:pmid
?:pmid
  • 32362061
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.625
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Dupilumab and COVID-19: What should we expect?
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all